Interview of the biotech company Lys Therapeutics by the journal “La Tribune de Lyon” and the journalist David GOSSART.

Here is the full article: https://tribunedelyon.fr/2021/09/28/une-nouvelle-molecule-pour-mieux-lutter-contre-lavc-developpee-par-une-entreprise-caenno-lyonnaise